Skip to content

13F-HR filed by Artal Group S.A.

Artal Group S.A. filed this 13F-HR for the quarter ended 2017-03-31, filed 2017-05-15, with 95 holding rows worth $4,505,103,000.

Accession
0001140361-17-020488
Filed
2017-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2017

A holdings report, 97 entries on the cover page, a total value of $4,505,103,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,505,103,000 with VALUE read as thousands by filing date, 13F file number 028-15027. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BLUE BUFFALO PET PRODS INC09531U102COM87,460,875$2,011,600,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK57,517,977$824,807,000thousands by filing date
WEIGHT WATCHERS INTL INC948626106COM29,443,300$458,432,000thousands by filing date
METLIFE INC COM59156R108Stock1,750,000$92,435,000thousands by filing datecall
Bank of America Corp060505104COM3,500,000$82,565,000thousands by filing datecall
Goldman Sachs Group,Inc.38141G104COM300,000$68,916,000thousands by filing datecall
Bristol-Myers Squibb Company110122108COM1,000,000$54,380,000thousands by filing datecall
Wells Fargo & Company949746101COM800,000$44,528,000thousands by filing datecall
AGIOS PHARMACEUTICALS INC00847X104COM750,000$43,800,000thousands by filing date
INCYTE CORP COM45337C102Stock325,000$43,443,000thousands by filing date
Gilead Sciences,Inc.375558103COM500,000$33,960,000thousands by filing datecall
CELGENE CORP151020104COM250,000$31,108,000thousands by filing datecall
Citigroup Inc.172967424COM500,000$29,910,000thousands by filing datecall
REGENERON PHARMACEUTICALS COM75886F107Stock75,000$29,063,000thousands by filing datecall
BIOMARIN PHARMACEUTICAL INC09061G101COM325,000$28,529,000thousands by filing date
ALIBABA GROUP HLDG LTD01609W102SPONSORED ADS250,000$26,958,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM1,000,000$23,470,000thousands by filing date
BLUEBIRD BIO INC09609G100COM250,000$22,725,000thousands by filing date
ATHENE HOLDING LTDG0684D107CL A450,000$22,496,000thousands by filing date
AMERICAN AIRLINES GROUP INC COM02376R102Stock500,000$21,150,000thousands by filing datecall
ACCELERON PHARMA INC00434H108COM750,000$19,853,000thousands by filing date
META PLATFORMS INC CL A30303M102COM125,000$17,756,000thousands by filing datecall
JPMorgan Chase & Co46625H100COM200,000$17,568,000thousands by filing datecall
International Business Machines Corporation459200101COM100,000$17,414,000thousands by filing datecall
ALIBABA GROUP HLDG LTD01609W102SPONSORED ADS150,000$16,175,000thousands by filing datecall
VANECK VECTORS ETF TR92189F718OIL SVCS ETF500,000$15,405,000thousands by filing datecall
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock300,000$15,375,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM325,000$14,073,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM1,900,000$13,547,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR363,286$13,300,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM175,000$12,437,000thousands by filing date
ZTO EXPRESS CAYMAN INC98980A105SPONSORED ADS A950,000$12,436,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK716,879$12,230,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM100,000$12,124,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS800,000$11,824,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM500,000$11,735,000thousands by filing datecall
Vertex Pharmaceuticals Incorporated92532F100COM100,000$10,935,000thousands by filing datecall
METLIFE INC COM59156R108Stock200,000$10,564,000thousands by filing date
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock500,000$10,275,000thousands by filing date
TESARO INC881569107COM66,400$10,217,000thousands by filing datecall
KITE PHARMA INC49803L109COM130,000$10,204,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock250,000$10,050,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW250,000$9,663,000thousands by filing date
AVEXIS INC05366U100COM120,000$9,124,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM300,000$8,880,000thousands by filing datecall
AGENUS INC00847G705COM NEW2,200,000$8,294,000thousands by filing date
IGNYTA INC451731103COM937,000$8,058,000thousands by filing date
TESARO INC881569107COM50,000$7,694,000thousands by filing date
ELFBEAUTYINC26856L103STOK250,000$7,200,000thousands by filing date
SERES THERAPEUTICS INC81750R102COM600,000$6,762,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock750,000$6,705,000thousands by filing date
JOUNCE THERAPEUTICS INC481116101COM300,000$6,597,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM175,000$6,449,000thousands by filing date
VERSARTIS INC92529L102COM300,000$6,405,000thousands by filing date
ALDER BIOPHARMACEUTICALS INC014339105COM300,000$6,240,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM200,000$5,920,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM100,000$5,840,000thousands by filing datecall
MACROGENICS INC556099109COM300,000$5,580,000thousands by filing date
AC IMMUNE SAH00263105SHS500,000$5,180,000thousands by filing date
MEDICINES CO584688105COM100,000$4,890,000thousands by filing date
SEATTLE GENETICS INC812578102COM75,000$4,715,000thousands by filing date
ZAFGEN INC98885E103COM1,000,000$4,660,000thousands by filing date
JUNO THERAPEUTICS INC48205A109COM200,000$4,438,000thousands by filing date
Bowater Inc09066L105COMMON STOCKS1,282,050$4,423,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM50,000$4,389,000thousands by filing datecall
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock500,000$4,200,000thousands by filing date
CHEMOCENTRYX INC16383L106COM546,278$3,977,000thousands by filing date
AIMMUNE THERAPEUTICS INC.00900T107Common Stock181,600$3,946,000thousands by filing date
AXOVANT SCIENCES LTDG0750W104COM250,000$3,735,000thousands by filing date
Intel Corp458140100COM100,000$3,607,000thousands by filing date
CELLECTIS ADS15117K103COM150,000$3,600,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J105COM250,000$3,523,000thousands by filing date
VITAL THERAPIES INC92847R104COM875,000$3,500,000thousands by filing date
CHIMERIX INC COM16934W106Stock500,000$3,190,000thousands by filing date
REGENXBIO INC75901B107COM160,000$3,088,000thousands by filing date
NOVELION THERAPEUTICS INC67001K202COM NEW256,400$2,754,000thousands by filing date
SYNDAX PHARMACEUTICALS INC87164F105COM200,000$2,744,000thousands by filing date
LOXO ONCOLOGY INC548862101COM65,000$2,735,000thousands by filing date
SPARK THERAPEUTICS INC84652J103COM50,000$2,667,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B103COM675,000$2,437,000thousands by filing date
MINERVA NEUROSCIENCES INC COM NEW603380106Stock251,300$2,036,000thousands by filing date
ULTRAGENYX PHARMACEUTICAL IN90400D108COM30,000$2,033,000thousands by filing date
PROQR THERAPEUTICS NVN71542109SHS EURO400,000$2,000,000thousands by filing date
ADAPTIMMUNE THERAPEUTICS PLC00653A107SPONDS ADR300,000$1,653,000thousands by filing date
ACHAOGEN INC004449104COM60,000$1,514,000thousands by filing date
ANAPTYSBIO INC032724106COM44,690$1,240,000thousands by filing date
JUNO THERAPEUTICS INC48205A109COM50,000$1,110,000thousands by filing datecall
CHINOOK THERAPEUTICS INC.00739L101Common Stock100,000$1,075,000thousands by filing date
ONCOCYTE CORP68235C107COM150,000$893,000thousands by filing date
STEMLINE THERAPEUTICS INC85858C107COM100,000$855,000thousands by filing date
NANTKWEST INC63016Q102COM225,000$799,000thousands by filing date
NEURODERM LTDM74231107ORD SHS25,000$664,000thousands by filing date
NOVAVAX INC670002104COMMON STOCK500,000$640,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock150,000$600,000thousands by filing date
DIMENSION THERAPEUTICS INC25433V105COM234,493$410,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-17-020488this filing2017-05-15acceptance time not in the bulk data set